Fig. 3. Time on ICI (in years) among patients with BRAF-altered lung cancer.

Patients still on treatment are denoted with arrows. Boxes at right indicate BRAF mutation Class (I–III indicates class), PD-L1 expression, and tumour mutation burden (TMB).